2 results
Contributors
-
- By Graeme J.M. Alexander, Heung Bae Kim, Michael Burch, Andrew J. Butler, Tanveer Butt, Roy Calne, Edward Cantu, Robert B. Colvin, Paul Corris, Charles Crawley, Hiroshi Date, Francis L. Delmonico, Bimalangshu R. Dey, Kate Drummond, John Dunning, John D. Firth, John Forsythe, Simon M. Gabe, Robert S. Gaston, William Gelson, Paul Gibbs, Alex Gimson, Leo C. Ginns, Samuel Goldfarb, Ryoichi Goto, Walter K. Graham, Simon J.F. Harper, Koji Hashimoto, David G. Healy, Hassan N. Ibrahim, David Ip, Fadi G. Issa, Neville V. Jamieson, David P. Jenkins, Dixon B. Kaufman, Kiran K. Khush, Heung Bae Kim, Andrew A. Klein, John Klinck, Camille Nelson Kotton, Vineeta Kumar, Yael B. Kushner, D. Frank. P. Larkin, Clive J. Lewis, Yvonne H. Luo, Richard S. Luskin, Ernest I. Mandel, James F. Markmann, Lorna Marson, Arthur J. Matas, Mandeep R. Mehra, Stephen J. Middleton, Giorgina Mieli-Vergani, Charles Miller, Sharon Mulroy, Faruk Özalp, Can Ozturk, Jayan Parameshwar, J.S. Parmar, Hari K. Parthasarathy, Nick Pritchard, Cristiano Quintini, Axel O. Rahmel, Chris J. Rudge, Stephan V.B. Schueler, Maria Siemionow, Jacob Simmonds, Peter Slinger, Thomas R. Spitzer, Stuart C. Sweet, Nina E. Tolkoff-Rubin, Steven S.L. Tsui, Khashayar Vakili, R.V. Venkateswaran, Hector Vilca-Melendez, Vladimir Vinarsky, Kathryn J. Wood, Heidi Yeh, David W. Zaas, Jonathan G. Zaroff
- Edited by Andrew A. Klein, Clive J. Lewis, Joren C. Madsen
-
- Book:
- Organ Transplantation
- Published online:
- 07 September 2011
- Print publication:
- 11 August 2011, pp vii-x
-
- Chapter
- Export citation
5 - Glutamate transporters
- from Part I - Basic aspects of neurodegeneration
-
- By Davide Trotti, Department of Neurology, Massachusetts General Hospital Harvard Medical School, Charlestown, MS, USA, Stuart L. Gibb, Massachusetts General Hospital Harvard Medical School, Charlestown, MS, USA
- M. Flint Beal, Cornell University, New York, Anthony E. Lang, University of Toronto, Albert C. Ludolph, Universität Ulm, Germany
-
- Book:
- Neurodegenerative Diseases
- Published online:
- 04 August 2010
- Print publication:
- 02 June 2005, pp 57-64
-
- Chapter
- Export citation
-
Summary
Introduction
In the central nervous system (CNS) of mammals, glutamate acts as a chemical transmitter of excitatory signals by binding to different glutamate receptors and activating a multitude of highly integrated molecular pathways. Termination of this excitatory neurotransmission occurs via re-uptake of glutamate by specialized high affinity transporters capable of maintaining glutamate at ∼1 μM levels in the synaptic cleft. At higher concentrations, glutamate can also act as neurotoxin causing degeneration and death of neurons (Choi, 1992). This event is known as excitotoxicity and contributes to many chronic and acute neurodegenerative diseases. Therefore, glutamate homeostasis and the regulation of glutamate transporter abundance and function are a key element for the normal brain function.
High affinity, Na+-dependent glutamate transporters: localization, functional properties and topology
Molecular cloning has identified five different subtypes of Na+-dependent glutamate transporters, termed EAAT1–5 (excitatory amino acid transporters 1–5; nomenclature used for human subtypes). At present, two different nomenclatures are in use in the literature to indicate human and rodent isoforms (Table 5.1). However, the homologues show a high degree of interspecies conservation (>95%) and do not differ functionally. The gene names for the human transporter are as follows: EAAT3 or SLC1A1; EAAT2 or SLC1A2; EAAT1 or SLC1A3; EAAT4 or SLC1A4; EAAT5 or SLC1A5. The acronym SLC1 refers to ‘Solute Carrier family’ number 1 and A1 to family member number 1.
Localization
Immunohistochemistry studies revealed that the glutamate transporters EAAT1 and EAAT2 are localized to astroglial membranes that immediately oppose synaptic cleft regions of the neuropil.